{
     "PMID": "1664338",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19920319",
     "LR": "20131121",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "207",
     "IP": "4",
     "DP": "1991 Aug 14",
     "TI": "Comparison of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD)- and 1R,3S-ACPD-stimulated brain phosphoinositide hydrolysis.",
     "PG": "351-3",
     "AB": "(1S,3R)-1-Aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) and (1R,3S)-1-aminocyclopentane-1,3-dicarboxylic acid (1R,3S-ACPD) were characterized for potency, efficacy, and selectivity at metabotropic excitatory amino acid receptors. 1S,3R-ACPD stimulated [3H]phosphoinositide hydrolysis in slices of the neonatal and adult rat hippocampus with full efficacy and twice the potency relative to what has been shown for (+/-)-trans-ACPD. 1S,3R-ACPD was up to 30 times more potent in activating metabotropic excitatory amino acid receptors, compared to its affinity for [3H]CGS19755 binding to NMDA receptors. In contrast, 1R,3S-ACPD was much less potent, efficacious, and selective than 1S,3R-ACPD. Although 1S,3R-ACPD is not specific, it is a most selective and efficacious agonist at metabotropic excitatory amino acid receptors.",
     "FAU": [
          "Schoepp, D D",
          "Johnson, B G",
          "True, R A",
          "Monn, J A"
     ],
     "AU": [
          "Schoepp DD",
          "Johnson BG",
          "True RA",
          "Monn JA"
     ],
     "AD": "Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article"
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Phosphatidylinositols)",
          "0 (Receptors, Amino Acid)",
          "0 (Receptors, Cell Surface)",
          "0TQU7668EI (Cycloleucine)",
          "111900-32-4 (1-amino-1,3-dicarboxycyclopentane)",
          "2552-55-8 (Ibotenic Acid)",
          "77521-29-0 (alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid)",
          "SIV03811UC (Kainic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain/drug effects/*metabolism",
          "Cycloleucine/*analogs & derivatives/pharmacology",
          "Hydrolysis/drug effects",
          "Ibotenic Acid/analogs & derivatives/metabolism",
          "Kainic Acid/metabolism",
          "Male",
          "Membranes/metabolism",
          "Phosphatidylinositols/*metabolism",
          "Rats",
          "Rats, Inbred Strains",
          "Receptors, Amino Acid",
          "Receptors, Cell Surface/metabolism",
          "Stimulation, Chemical",
          "alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid"
     ],
     "EDAT": "1991/08/14 00:00",
     "MHDA": "1991/08/14 00:01",
     "CRDT": [
          "1991/08/14 00:00"
     ],
     "PHST": [
          "1991/08/14 00:00 [pubmed]",
          "1991/08/14 00:01 [medline]",
          "1991/08/14 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 1991 Aug 14;207(4):351-3.",
     "term": "hippocampus"
}